San Carlos, CA, United States of America

Jolad D Shivanand

This inventor holds 1 USPTO granted patent. Top assignee: Shaman Pharmaceuticals, Inc.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jolad D Shivanand. Retrieved from https://idiyas.com/inventor/jolad-d-shivanand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jolad D Shivanand

Introduction

Jolad D Shivanand is an accomplished inventor based in San Carlos, CA (US). He has made significant contributions to the field of diabetes treatment through his innovative research and development of novel compounds.

Latest Patents

Shivanand holds a patent for "Terpenoid-type quinones for treatment of diabetes." This patent describes novel terpenoid-type quinones that can be obtained from Pycnanthus spp. The processes for obtaining these quinones and their methods of use as hypoglycemic agents are detailed in the patent. In a preferred embodiment, these terpenoid-type quinones are derived from the leaves and stems of Pycnanthus angolensis. They are particularly useful for treating both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes.

Career Highlights

Shivanand is associated with Shaman Pharmaceuticals, Inc., where he has been instrumental in advancing research related to diabetes treatment. His work has focused on the development of effective therapeutic agents that can improve the quality of life for individuals suffering from diabetes.

Collaborations

Some of his notable coworkers include Rosa P Ubillas and Christopher D Mendez, who have collaborated with him on various projects within the pharmaceutical field.

Conclusion

Jolad D Shivanand's innovative work in the development of terpenoid-type quinones represents a significant advancement in diabetes treatment. His contributions continue to impact the field positively, showcasing the importance of research and innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…